the progression of Parkinson���s. The procedure depends on a radioactive drug, ioflupane, approved in January by the Food and Drug Administration. Parkinson���s disease is characterized by diminishing supplies of dopamine, neurotransmitters in the brain...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to The New Old Age: A Portrait of Parkinson's Disease
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account